Abstract is: Polycystic liver disease (PLD) usually describes the presence of multiple cysts scattered throughout normal liver tissue. PLD is commonly seen in association with autosomal-dominant polycystic kidney disease, with a prevalence of 1 in 400 to 1000, and accounts for 8–10% of all cases of end-stage renal disease. The much rarer autosomal-dominant polycystic liver disease will progress without any kidney involvement.
| rare disease | Q929833 |
| class of disease | Q112193867 |
| liver disease | Q929737 |
| autosomal dominant disease | Q18553439 |
| P699 | Disease Ontology ID | DOID:0050770 |
| P557 | DiseasesDB | 33340 |
| P2888 | exact match | http://identifiers.org/doid/DOID:0050770 |
| http://purl.obolibrary.org/obo/DOID_0050770 | ||
| http://purl.obolibrary.org/obo/DOID_1173 | ||
| http://purl.obolibrary.org/obo/HP_0006557 | ||
| P4317 | GARD rare disease ID | 9457 |
| P3841 | Human Phenotype Ontology ID | HP:0006557 |
| P494 | ICD-10 ID | Q44.6 |
| P7807 | ICD-11 ID (Foundation) | 1361740083 |
| 557775192 | ||
| P7329 | ICD-11 ID (MMS) | LB20.00 |
| P1692 | ICD-9-CM | 751.62 |
| P665 | KEGG ID | H00545 |
| P3201 | Medical Dictionary for Regulatory Activities ID | 10010427 |
| 10010427 | ||
| P486 | MeSH descriptor ID | C536330 |
| P6366 | Microsoft Academic ID | 2780021040 |
| P5270 | Mondo ID | MONDO_0000447 |
| P1748 | NCI Thesaurus ID | C82833 |
| P492 | OMIM ID | 174050 |
| 174050 | ||
| P10283 | OpenAlex ID | C2780021040 |
| P1550 | Orphanet ID | 2924 |
| P4233 | PatientsLikeMe condition ID | polycystic-liver |
| P3417 | Quora topic ID | Polycystic-Liver-Disease |
| P2892 | UMLS CUI | C0158683 |
| C4255088 | ||
| P11143 | WikiProjectMed ID | Polycystic liver disease |
| P2293 | genetic association | PRKCSH | Q18030781 |
| SEC63 | Q18036417 | ||
| P1995 | health specialty | medical genetics | Q1071953 |
| P5008 | on focus list of Wikimedia project | WikiProject Medicine | Q4099686 |
| P780 | symptoms and signs | hepatic cyst | Q1811141 |
| Q39153402 | A 20-year experience with liver transplantation for polycystic liver disease: does previous palliative surgical intervention affect outcomes? |
| Q92267331 | A Practical Approach to Polycystic Liver Disease |
| Q52994465 | A liver with polycystic liver disease as graft for orthotopic liver transplantation. |
| Q47305691 | A non-coding variant in GANAB explains isolated polycystic liver disease (PCLD) in a large family. |
| Q57149503 | A novel twist in polycystic liver disease |
| Q67988288 | Acute Budd-Chiari's syndrome after surgical treatment of polycystic liver disease |
| Q69740063 | Adult polycystic liver disease and biliary microhamartomas (von Meyenburg's complexes) |
| Q38761863 | Adult polycystic liver disease concomitant with severe anemia due to intracystic bleeding is an indication for liver transplantation: case report and review of literature |
| Q44049483 | Adult polycystic liver disease in alpacas |
| Q69642746 | Adult polycystic liver disease in childhood. A case report |
| Q81413165 | Adult polycystic liver disease presenting as portal hypertension |
| Q54066424 | Adult polycystic liver disease presenting in a patient with metastatic adenocarcinoma. Cytologic and histologic findings |
| Q77656051 | Adult polycystic liver disease with cutaneous involvement: a brief report |
| Q73132254 | Adult polycystic liver disease: is fenestration the most adequate operation for long-term management? |
| Q39481673 | Alcohol sclerosis for polycystic liver disease and obstructive jaundice: use of a nasobiliary catheter. |
| Q33873050 | Alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a pooled analysis |
| Q85623809 | An Unusual Cause of a High Carbonhydrate Antigen 19-9 Level in an Elderly Individual: Polycystic Liver Disease |
| Q57111089 | An in vitro model of polycystic liver disease using genome-edited human inducible pluripotent stem cells |
| Q24337764 | An interaction between human Sec63 and nucleoredoxin may provide the missing link between the SEC63 gene and polycystic liver disease |
| Q96589171 | Anterior approach for hepatectomy before piggy-back liver transplantation in giant polycystic liver disease |
| Q41094402 | Autosomal dominant polycystic liver disease as an etiology for hemoperitoneum during CCPD. |
| Q36503333 | Autosomal dominant polycystic liver disease in a family without polycystic kidney disease associated with a novel missense protein kinase C substrate 80K-H mutation |
| Q70449111 | Autosomal dominant polycystic liver disease: a second family |
| Q70951343 | Benign polycystic liver disease |
| Q83640418 | Boy with autosomal recessive polycystic kidney and autosomal dominant polycystic liver disease |
| Q84040638 | Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease |
| Q96687682 | Cardiac compression of a hepatic cyst in polycystic liver disease: A rare cause of hemodynamic instability |
| Q66984282 | Case of the month No. 39: Polycystic liver disease |
| Q39317789 | Choice of transplantation techniques and indications for liver transplantation in polycystic liver disease in patients with no signs of end-stage liver disease |
| Q47662845 | Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target |
| Q47137161 | Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes |
| Q44237811 | Clinical outcomes of liver transplantation for polycystic liver disease: a single center experience |
| Q36065750 | Combined hepatic resection with fenestration for highly symptomatic polycystic liver disease: A report on seven patients |
| Q46412138 | Combined left hepatectomy with fenestration and using a harmonic scalpel, fibrin glue and closed suction drainage to prevent bile leakage and ascites in the management of symptomatic polycystic liver disease: a case report. |
| Q33759058 | Combined liver and kidney transplant in a patient with budd-Chiari syndrome secondary to autosomal dominant polycystic kidney disease associated with polycystic liver disease: report of a case with a 9-year follow-up |
| Q41100532 | Comparison of volume-reductive therapies for massive polycystic liver disease in autosomal dominant polycystic kidney disease. |
| Q74615326 | Complicated polycystic liver disease with intracystic hemorrhage and obstructive jaundice |
| Q39300878 | Current treatment status of polycystic liver disease in Japan |
| Q80559144 | Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p |
| Q86368058 | Development and validation of a polycystic liver disease complaint-specific assessment (POLCA) - use of the Delphi technique for content validation |
| Q38226375 | Development and validation of a polycystic liver disease complaint-specific assessment (POLCA). |
| Q57298238 | Drug holiday in patients with polycystic liver disease treated with somatostatin analogues |
| Q36926935 | Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease |
| Q92275874 | Effects of Long-Term Exercise on Liver Cyst in Polycystic Liver Disease Model Rats |
| Q101217999 | Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county |
| Q92804537 | Estrogen-Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients |
| Q48121526 | Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume |
| Q85006225 | Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study |
| Q39277652 | Extended liver resection for polycystic liver disease can challenge liver transplantation. |
| Q79887081 | Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease |
| Q37267292 | Factors that influence outcome in non-invasive and invasive treatment in polycystic liver disease patients |
| Q47625769 | Fatal liver cyst rupture in polycystic liver disease complicated with autosomal dominant polycystic kidney disease: A case report. |
| Q45011544 | Feeding soy protein isolate and n-3 PUFA affects polycystic liver disease progression in a PCK rat model of autosomal polycystic kidney disease. |
| Q35826307 | Fenestration of liver cysts in polycystic liver disease to improve quality of life: a case report and literature review |
| Q45221239 | Fenestration treatment for polycystic liver disease improved quality of life. |
| Q46895052 | Fulminant liver failure in a patient affected by polycystic liver disease and liver metastases from breast carcinoma. |
| Q91510637 | Further Evidence That Lanreotide Reduces Liver Growth in Patients With Polycystic Liver Disease, But Not the End of the Story |
| Q96576611 | Ganab Haploinsufficiency Does Not Cause Polycystic Kidney Disease or Polycystic Liver Disease in Mice |
| Q88187890 | Genetics: Novel causative genes for polycystic liver disease |
| Q28208353 | Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease |
| Q57147812 | Hepatic Intracystic Organizing Hematoma Mimicking Biliary Cystadenocarcinoma in a Patient with Polycystic Liver Disease |
| Q77734841 | Hepatic lymphangiomatosis mimicking polycystic liver disease |
| Q85275879 | Hepatic resection for giant haemangioma in a patient with a contemporaneous adult polycystic liver disease |
| Q34407526 | Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment |
| Q81709549 | Hepatocellular apoptosis in polycystic liver disease |
| Q42633713 | Highly symptomatic adult polycystic liver disease: options and results of surgical management |
| Q24538950 | Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1 |
| Q83893597 | Image of the month. Polycystic liver disease leading to liver failure and transplantation |
| Q80147125 | Images in clinical medicine. Liver transplantation for polycystic liver disease |
| Q90735242 | Intracystic Hemorrhage Complicating Polycystic Liver Disease in a 90-Year-Old Woman |
| Q91854753 | Intravascular US Guidance for Direct Intrahepatic Portosystemic Shunt Creation in the Setting of Polycystic Liver Disease |
| Q55406157 | Isolated Polycystic Liver Disease: An Unusual Cause of Recurrent Variceal Bleed. |
| Q42770189 | Isolated polycystic liver disease and aneurism: a case report |
| Q59463047 | Isolated polycystic liver disease as a distinct genetic disease, unlinked to polycystic kidney disease 1 and polycystic kidney disease 2 |
| Q38708994 | Isolated polycystic liver disease genes define effectors of polycystin-1 function |
| Q88894723 | Isolated polycystic liver disease genes define effectors of polycystin-1 function |
| Q74578499 | Isolated polycystic liver disease not linked to polycystic kidney disease 1 and 2 |
| Q77638050 | Laparoscopic Lin operation for the treatment of polycystic liver disease |
| Q50243814 | Laparoscopic deroofing for polycystic liver disease using laparoscopic fusion indocyanine green fluorescence imaging |
| Q57781628 | Laparoscopic fenestration for the treatment of patients with severe adult polycystic liver disease |
| Q51731366 | Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%. |
| Q95830519 | Laparoscopic hepatic lobectomy for symptomatic polycystic liver disease |
| Q80051551 | Laparoscopic right hemihepatectomy for a case of polycystic liver disease with right predominance |
| Q37028071 | Laparoscopic surgery and polycystic liver disease: Clinicopathological features and new trends in management |
| Q78947859 | Laparoscopic treatment of simple hepatic cysts and polycystic liver disease |
| Q74440745 | Lipoma of the liver associated with hepatocellular carcinoma and polycystic liver disease |
| Q50320894 | Liver Transplant for Unusually Large Polycystic Liver Disease: Challenges and Pitfalls. |
| Q87666194 | Liver Transplantation for Polycystic Liver Disease Due to Huge Liver With Related Complications: A Case Report |
| Q73824072 | Liver transplantation for adult polycystic liver disease |
| Q84969522 | Liver transplantation for massive hepatomegaly due to polycystic liver disease: an extreme case |
| Q68765663 | Liver transplantation for polycystic liver disease |
| Q89615743 | Liver transplantation in a patient with massive polycystic liver disease |
| Q37304564 | Liver transplantation in polycystic liver disease: a relevant treatment modality for adults? |
| Q81142477 | Living donor liver transplantation in polycystic liver disease |
| Q78600097 | Living related liver transplantation for polycystic liver disease |
| Q76334147 | Living-donor liver transplantation for polycystic liver disease |
| Q92562303 | Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis |
| Q64111335 | Long-term results of liver transplantation for polycystic liver disease: Single-center experience in China |
| Q70708501 | Low high-density lipoprotein and reduced antipyrine metabolism in members of a family with polycystic liver disease |
| Q69881859 | MR imaging of a hemorrhagic hepatic cyst in a patient with polycystic liver disease |
| Q68213927 | MR imaging of multiple hepatic cysts in a patient with polycystic liver disease |
| Q70747245 | MRI and CT features of polycystic liver disease |
| Q81382267 | Management of polycystic liver disease |
| Q90032067 | Management of portal hypertension and ascites in polycystic liver disease |
| Q86062921 | Management of symptomatic polycystic liver disease with hepatic resection |
| Q54010882 | Management of symptomatic polycystic liver disease: laparoscopy adjuvant with alcohol sclerotherapy. |
| Q68131756 | Massive hepatomegaly in adult polycystic liver disease |
| Q36075880 | Meningeal tumor: A rare extrahepatic association in patients with polycystic liver disease enrolled for liver transplantation |
| Q79378925 | Model for end-stage liver disease (MELD) exception for polycystic liver disease |
| Q93172834 | Modified Technique of Total Hepatectomy in Polycystic Liver Disease With Caval Flow Preservation: The Exposure Left Lateral Sectionectomy |
| Q88177247 | Multicentric Study of the Andalusian Experience in Polycystic Liver Disease as Indication for Liver Transplantation |
| Q24531988 | Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease |
| Q28260838 | Mutations in SEC63 cause autosomal dominant polycystic liver disease |
| Q40835900 | Necrotic melanocytoma associated with polycystic liver disease and cutaneous neurofribomata. |
| Q36918861 | Neuroendocrine tumor in the liver of a patient with isolated polycystic liver disease: A case report and review of the literature |
| Q90126279 | New synthetic conjugates of ursodeoxycholic acid inhibit cystogenesis in experimental models of polycystic liver disease |
| Q39495734 | Non-parasitic liver cysts and polycystic liver disease: results of surgical treatment |
| Q100957037 | Novel GANAB variants associated with polycystic liver disease |
| Q71278910 | Obstructive jaundice caused by polycystic liver disease |
| Q91532727 | Obstructive jaundice in a patient with polycystic liver disease complicated with polycystic kidney and polycystic lung: A case report |
| Q34785111 | Obstructive jaundice in polycystic liver disease related to coexisting cholangiocarcinoma |
| Q53563592 | Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate. |
| Q39465440 | Orthotopic liver transplantation in therapy of advanced polycystic liver disease |
| Q51801915 | Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation. |
| Q28595645 | Outcomes and Durability of Hepatic Reduction after Combined Partial Hepatectomy and Cyst Fenestration for Massive Polycystic Liver Disease |
| Q83523531 | PRKCSH genetic mutation was not found in Taiwanese patients with polycystic liver disease |
| Q24321394 | PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation |
| Q71270516 | Partial resection and fenestration in the treatment of polycystic liver disease |
| Q51570027 | Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases. |
| Q39295393 | Percutaneous aspiration and ethanolamine oleate sclerotherapy for sustained resolution of symptomatic polycystic liver disease: an initial experience |
| Q70776422 | Percutaneous sclerosis of hepatic cysts to treat obstructive jaundice in a patient with polycystic liver disease |
| Q36718790 | Peri-operative challenges and long-term outcomes in liver transplantation for polycystic liver disease |
| Q49790267 | Polycystic Liver Disease Presenting as Expanding Mass Following Cholecystectomy |
| Q37666139 | Polycystic Liver Disease and Sarcoidosis: Unusual Coexisting Etiologies of Portal Hypertension |
| Q44263308 | Polycystic Liver Disease in Senile Chamois (Rupicaprae rupicaprae) |
| Q90050677 | Polycystic Liver Disease in a Patient With Metastatic Renal Cell Carcinoma: A Case Report |
| Q91767316 | Polycystic Liver Disease with Huge Infected Cyst Displacing the Pancreas, Inferior Vena Cava and Right Kidney |
| Q42634983 | Polycystic Liver Disease: The Benefits of Targeting cAMP. |
| Q50048998 | Polycystic Liver Disease: The interplay of genes causative for hepatic and renal cystogenesis |
| Q84909995 | Polycystic liver disease and liver transplantation: single-institution experience |
| Q86997345 | Polycystic liver disease complicated by obstructive jaundice |
| Q43610262 | Polycystic liver disease in golden hamsters |
| Q69003062 | Polycystic liver disease in two sisters |
| Q36009020 | Polycystic liver disease is a disorder of cotranslational protein processing. |
| Q78654233 | Polycystic liver disease is genetically heterogeneous: clinical and linkage studies in eight Finnish families |
| Q72688381 | Polycystic liver disease mimicking sclerosing cholangitis during endoscopic retrograde cholangiopancreatography |
| Q53082358 | Polycystic liver disease presenting as acute abdomen. |
| Q37647738 | Polycystic liver disease presenting as pruritus |
| Q35950651 | Polycystic liver disease presenting with an exudative pleural effusion: a case report |
| Q72123826 | Polycystic liver disease treated by fenestration and segmental liver resection |
| Q84559917 | Polycystic liver disease treated with therapeutic excision |
| Q54439390 | Polycystic liver disease with chemical analysis of the cyst fluid |
| Q85847226 | Polycystic liver disease with complications: fenestration by laparoscopic approach |
| Q52991315 | Polycystic liver disease with no renal involvement. |
| Q39504816 | Polycystic liver disease with obstructive jaundice: treatment with ultrasound-guided cyst aspiration |
| Q79612154 | Polycystic liver disease with portal hypertension |
| Q99563851 | Polycystic liver disease, an atypical cause of cardiac tamponade |
| Q50137685 | Polycystic liver disease, complicated by Salmonella infection |
| Q90779857 | Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management |
| Q50098684 | Polycystic liver disease: Hepatic venous outflow obstruction lesions of the non-cystic parenchyma have major consequences |
| Q27010247 | Polycystic liver disease: a clinical review |
| Q39301621 | Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation |
| Q82971663 | Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation |
| Q41622768 | Polycystic liver disease: a study of cyst fluid constituents. |
| Q33648233 | Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management |
| Q33537926 | Polycystic liver disease: an unusual cause of bleeding varices |
| Q40504519 | Polycystic liver disease: case report |
| Q38186149 | Polycystic liver disease: ductal plate malformation and the primary cilium |
| Q36266530 | Polycystic liver disease: experience at a teaching hospital |
| Q70962783 | Polycystic liver disease: immunohistochemical characterization of cyst epithelia and extracellular matrix |
| Q36652708 | Polycystic liver disease: multimodality imaging for complications and transplant evaluation |
| Q83182810 | Polycystic liver disease: new insights into disease pathogenesis |
| Q67970204 | Polycystic liver disease: quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts |
| Q72329277 | Polycystic liver disease: scintigraphic and angiographic discovery associated with cirrhosis |
| Q47889187 | Polycystic liver disease: studies on the mechanisms of cyst fluid formation. A case report |
| Q51733337 | Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease. |
| Q33437890 | Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes |
| Q46289076 | Portal hypertensive enteropathy in a patient with polycystic liver disease: a unique endoscopic finding |
| Q77093663 | Pregnancy complicated by symptomatic adult polycystic liver disease |
| Q90205315 | Preserving the organ donor pool and suprahepatic vena cava: Case series of transverse hepatectomy for polycystic liver disease |
| Q94601043 | Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets |
| Q64238045 | Recurrent acute pancreatitis in a patient with both gallbladder and cystic duct agenesis and polycystic liver disease |
| Q64266041 | Recurrent renal cell carcinoma leading to a misdiagnosis of polycystic liver disease: A case report |
| Q54448998 | Reply to: "Development and validation of a polycystic liver disease complaint-specific assessment (POLCA) - use of the Delphi technique for content validation". |
| Q30430246 | Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease |
| Q86935239 | Risk factors for progressive polycystic liver disease: where do we stand? |
| Q87103738 | Ruptured cerebral aneurysm and acute bilateral carotid artery dissection in a patient with polycystic kidney disease and polycystic liver disease |
| Q30651564 | Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data. |
| Q88008527 | Scanning electron microscopy of polycystic liver disease |
| Q73332776 | Screening for cerebral aneurysm in patients with polycystic liver disease |
| Q77562528 | Screening for intracranial aneurysms in patients with isolated polycystic liver disease |
| Q30384755 | Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. |
| Q79307949 | Serial needle aspiration in polycystic liver disease |
| Q55043077 | Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene. |
| Q97875741 | Severe Polycystic Liver Disease with Hepatic Cyst Infection |
| Q98612479 | Severe polycystic liver disease as a rare indication for liver transplantation |
| Q91501821 | Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry |
| Q36208594 | Somatostatin analog therapy for severe polycystic liver disease: results after 2 years |
| Q40780575 | Somatostatin analogues improve health-related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo-controlled trials |
| Q53024282 | Stroke after cyst fenestration in a patient with autosomal dominant polycystic kidney disease and polycystic liver disease: Not necessarily aneurysm-related. |
| Q74440740 | Successful left trisegmentectomy for polycystic liver disease accompanied by jaundice |
| Q73930523 | Successful transjugular intrahepatic portosystemic shunt creation in a patient with polycystic liver disease |
| Q72600322 | Surgery for adult polycystic liver disease |
| Q35615791 | Surgical management of polycystic liver disease |
| Q70897802 | Surgical resection in symptomatic polycystic liver disease |
| Q94661629 | Symptom relief and quality of life after combined partial hepatectomy and cyst fenestration in highly symptomatic polycystic liver disease |
| Q74319104 | Symptomatic adult polycystic liver disease |
| Q67783317 | Symptomatic adult polycystic liver disease in a young woman |
| Q53086111 | Symptomatic polycystic liver disease treated with transcatheter hepatic arterial embolization and inferior vena cava stenting: a case report. |
| Q40595292 | Symptomatic polycystic liver disease: a case report and review of the literature |
| Q59790799 | TIMING AND TREATMENT OPTIONS IN ADULT POLYCYSTIC LIVER DISEASE: A RARE FAMILIAR CASE AS EXAMPLE |
| Q99575534 | Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models |
| Q77553146 | The effect of fenestration procedure on liver regeneration in a case of polycystic liver disease |
| Q70267105 | The gallbladder in polycystic liver disease |
| Q70834003 | The gallbladder in polycystic liver disease |
| Q51490969 | The long-term outcome of patients with polycystic liver disease treated with lanreotide. |
| Q92687098 | The management of polycystic liver disease by tolvaptan |
| Q83333280 | Therapeutic challenge of ERCP for biliary decompression in a patient with autosomal dominant polycystic kidney disease and polycystic liver disease and pancreaticoduodenectomy anatomy |
| Q68142491 | Therapeutic dilemmas in patients with symptomatic polycystic liver disease |
| Q38641525 | Transarterial Embolization for Treatment of Symptomatic Polycystic Liver Disease: More than 2-year Follow-up |
| Q90259727 | Transarterial embolisation with bleomycin and N-butyl-2-cyanoacrylate -Lipiodol mixture for symptomatic polycystic liver disease: preliminary experience |
| Q37726026 | Transgastric removal of a polycystic liver disease using mini-laparoscopic excision |
| Q73815673 | Transjugular intrahepatic portosystemic shunt for the treatment of intractable ascites in a patient with polycystic liver disease |
| Q74459744 | Transjugular intrahepatic portosystemic shunt placement in the setting of polycystic liver disease: questioning the contraindication |
| Q73417084 | Transverse hepatectomy for symptomatic polycystic liver disease |
| Q84913768 | Treatment of polycystic liver disease |
| Q42783863 | Treatment of polycystic liver disease with percutaneous injection of acetic acid |
| Q37344254 | Treatment of polycystic liver disease with resection-fenestration and a new classification |
| Q45212355 | Treatment of polycystic liver disease: a hypothesis, patient characteristics, short and long-term results. |
| Q47286206 | Treatment of polycystic liver disease: one size does not fit all. |
| Q78389296 | Treatment of symptomatic polycystic liver disease with resection-fenestration |
| Q39245716 | Treatment of symptomatic polycystic liver disease: transcatheter super-selective hepatic arterial embolization using a mixture of NBCA and iodized oil. |
| Q73206214 | Unusual presentation of polycystic liver disease in a young man |
| Q38863947 | Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial |
| Q90039944 | Venous Stent Placement for Refractory Ascites due to Hepatic Venous Outflow Obstruction in Polycystic Liver Disease |
| Q38906055 | Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure |
| Q30624476 | Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data |
| Q73741984 | [From gene to disease; hepatocystin and autosomal dominant polycystic liver disease] |
| Q74223696 | [Gastrointestinal surgery and gastroenterology. XV. Polycystic liver disease] |
| Q80278639 | [Genetic defects underlying polycystic liver disease are discovered] |
| Q74002807 | [Hereditary polycystic liver disease] |
| Q57139912 | [Jaundice secondary to bile duct obstruction by polycystic liver disease] |
| Q73505692 | [Laparoscopic fenestration in the management of symptomatic polycystic liver disease] |
| Q77375379 | [Liver resection in patients with polycystic liver disease] |
| Q92450119 | [Liver transplantation for polycystic liver disease: 11 cases report and literature review] |
| Q74531753 | [Massive polycystic liver disease with rapid evolution: report of a case] |
| Q54615477 | [Orthotopic liver transplantation for polycystic liver disease with massive hepatomegaly]. |
| Q78768606 | [Polycystic liver disease and its main complications] |
| Q71476433 | [Polycystic liver disease with abdominal pain and jaundice treated by two successive "fenestration" procedure (author's transl)] |
| Q79348063 | [Polycystic liver disease without autosomal dominant polycystic kidney disease] |
| Q70682150 | [Polycystic liver disease: considerations on a clinical case] |
| Q73074873 | [Pseudocystic metastases of carcinoma of the uterine cervix mimicking polycystic liver disease] |
| Q78023278 | [Solitary liver cysts and polycystic liver disease: aspects of surgical management of congenital cystic liver disease] |
| Q84974339 | [Surgical treatment of symptomatic polycystic liver disease, an uncommon problem without systematic approach] |
| Q82768174 | [Therapeutical effect of combined hepatic resection and fenestration on patients with severe adult polycystic liver disease] |
| Q18036417 | SEC63 | genetic association | P2293 |
| Q37807576 | Hepatic Neoplasia and Metabolic Diseases in Children | cites work | P2860 |
| Arabic (ar / Q13955) | مرض الكبد متعدد الكيسات | wikipedia |
| Zystenleber | wikipedia | |
| Polycystic liver disease | wikipedia | |
| Polykystinen maksatauti | wikipedia | |
| Polycysteuze leverziekte | wikipedia | |
| Policistična bolest jetre | wikipedia |
Search more.